TY - JOUR
KW - Construct Validity
KW - content validity
KW - Questionnaire validation
KW - questionnaire development
KW - Validation
KW - India
KW - leprosy
AU - Komrraju S
AU - Sathyanath D
AU - Kumar N
AU - Shrikanth M
AB - <p><strong>Background: </strong></p>

<p>Leprosy persists as a social and health issue in India, requiring validated tools to evaluate perspectives on stigma, knowledge, and needs. This study developed and validated a questionnaire with domains: sociodemographics, living conditions, health status and practices, knowledge about leprosy, and felt needs and priorities.</p>

<p><strong>Methods:</strong></p>

<p>Cross-sectional validation with 138 participants from Antulay Nagar, Pune, January–June 2024. Content validity via expert panel (I-CVI, S-CVI/Ave). Construct validity using EFA (KMO = 0.82, Bartlett’s χ² = 1265.4, P &lt; 0.001). Reliability with Cronbach’s alpha.</p>

<p><strong>Results:</strong></p>

<p>I-CVI 0.75–1.00, S-CVI/Ave 0.90; three items revised. Five factors emerged with loadings &gt;0.60. Cronbach’s alpha 0.79–0.88.</p>

<p><strong>Conclusion:</strong></p>

<p>The questionnaire is valid and reliable for assessing social perspectives in leprosy settings.</p>

BT - Journal of Pharmacy and Bioallied Sciences
DA - 12/2025
DO - 10.4103/jpbs.jpbs_1557_25
LA - ENG
M3 - Article 
N2 - <p><strong>Background: </strong></p>

<p>Leprosy persists as a social and health issue in India, requiring validated tools to evaluate perspectives on stigma, knowledge, and needs. This study developed and validated a questionnaire with domains: sociodemographics, living conditions, health status and practices, knowledge about leprosy, and felt needs and priorities.</p>

<p><strong>Methods:</strong></p>

<p>Cross-sectional validation with 138 participants from Antulay Nagar, Pune, January–June 2024. Content validity via expert panel (I-CVI, S-CVI/Ave). Construct validity using EFA (KMO = 0.82, Bartlett’s χ² = 1265.4, P &lt; 0.001). Reliability with Cronbach’s alpha.</p>

<p><strong>Results:</strong></p>

<p>I-CVI 0.75–1.00, S-CVI/Ave 0.90; three items revised. Five factors emerged with loadings &gt;0.60. Cronbach’s alpha 0.79–0.88.</p>

<p><strong>Conclusion:</strong></p>

<p>The questionnaire is valid and reliable for assessing social perspectives in leprosy settings.</p>

PB - Ovid Technologies (Wolters Kluwer Health)
PY - 2025
SP - 1
EP - 3
T2 - Journal of Pharmacy and Bioallied Sciences
TI - Development and Validation of a Questionnaire to Assess Social Perspectives Among Leprosy-Affected Individuals in a Rehabilitation Colony in Pune, Maharashtra, India
UR - https://deleprastichting-my.sharepoint.com/:b:/g/personal/e_williams_infontd_org/IQBvX0WYEVdOTZm_CKr2iE2rAUcEs8wNvc314gLp5ZnisGU?e=DxLeNf
SN - 0976-4879, 0975-7406
ER -